Found: 89
Select item for more details and to access through your institution.
Expression of ISL1 and its partners in prostate cancer progression and neuroendocrine differentiation.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2021, v. 147, n. 8, p. 2223, doi. 10.1007/s00432-021-03634-2
- By:
- Publication type:
- Article
Validation of a 10-gene molecular signature for predicting biochemical recurrence and clinical metastasis in localized prostate cancer.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2018, v. 144, n. 5, p. 883, doi. 10.1007/s00432-018-2615-7
- By:
- Publication type:
- Article
The Association Between Vasectomy and Prostate Cancer: A Systematic Review and Meta-analysis.
- Published in:
- 2017
- By:
- Publication type:
- journal article
20-year survival after radical prostatectomy as initial treatment for cT3 prostate cancer.
- Published in:
- BJU International, 2012, v. 110, n. 11, p. 1709, doi. 10.1111/j.1464-410X.2012.11372.x
- By:
- Publication type:
- Article
Contemporary trends of in-hospital complications and mortality for radical cystectomy.
- Published in:
- BJU International, 2012, v. 110, n. 8, p. 1163, doi. 10.1111/j.1464-410X.2012.10990.x
- By:
- Publication type:
- Article
Dynamic prediction of metastases after radical prostatectomy for prostate cancer.
- Published in:
- BJU International, 2011, v. 108, n. 11, p. 1762, doi. 10.1111/j.1464-410X.2011.10208.x
- By:
- Publication type:
- Article
The effect of Gleason score on the predictive value of prostate-specific antigen doubling time.
- Published in:
- BJU International, 2010, v. 105, n. 10, p. 1381, doi. 10.1111/j.1464-410X.2009.08976.x
- By:
- Publication type:
- Article
Impact of prostate-specific antigen testing on the clinical and pathological outcomes after radical prostatectomy for Gleason 8–10 cancers.
- Published in:
- BJU International, 2008, v. 101, n. 3, p. 299, doi. 10.1111/j.1464-410X.2007.07269.x
- By:
- Publication type:
- Article
Dual inhibition of AKT‐mTOR and AR signaling by targeting HDAC3 in <italic>PTEN</italic>‐ or <italic>SPOP</italic>‐mutated prostate cancer.
- Published in:
- EMBO Molecular Medicine, 2018, v. 10, n. 4, p. 1, doi. 10.15252/emmm.201708478
- By:
- Publication type:
- Article
Development and Validation of a Novel TP53 Mutation Signature That Predicts Risk of Metastasis in Primary Prostate Cancer.
- Published in:
- Clinical Genitourinary Cancer, 2021, v. 19, n. 3, p. 246, doi. 10.1016/j.clgc.2020.08.004
- By:
- Publication type:
- Article
Radium-223 in the Third-Line Setting in Metastatic Castration-Resistant Prostate Cancer: Impact of Concomitant Use of Enzalutamide on Overall Survival (OS) and Predictors of Improved OS.
- Published in:
- Clinical Genitourinary Cancer, 2021, v. 19, n. 3, p. 223, doi. 10.1016/j.clgc.2020.12.009
- By:
- Publication type:
- Article
The Role of Adjuvant Hormonal Treatment after Surgery for Localized High-Risk Prostate Cancer: Results of a Matched Multiinstitutional Analysis.
- Published in:
- Advances in Urology, 2012, p. 1, doi. 10.1155/2012/612707
- By:
- Publication type:
- Article
MYC drives aggressive prostate cancer by disrupting transcriptional pause release at androgen receptor targets.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-30257-z
- By:
- Publication type:
- Article
SPOP mutation induces DNA methylation via stabilizing GLP/G9a.
- Published in:
- Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-25951-3
- By:
- Publication type:
- Article
A noncanonical AR addiction drives enzalutamide resistance in prostate cancer.
- Published in:
- Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-21860-7
- By:
- Publication type:
- Article
Localized Prostate Cancer Recurrence.
- Published in:
- Applied Radiology, 2021, v. 50, n. 2, p. 32
- By:
- Publication type:
- Article
Response to letter: 'Testis is a content of the superficial perineal pouch: Why is it overlooked by authors of textbooks?' by Lobo and Mezezes.
- Published in:
- Clinical Anatomy, 2008, v. 21, n. 6, p. 605, doi. 10.1002/ca.20674
- By:
- Publication type:
- Article
A noninvasive multi-analyte diagnostic assay: combining protein and DNA markers to stratify bladder cancer patients.
- Published in:
- Research & Reports in Urology, 2012, n. 4, p. 17, doi. 10.2147/RRU.S28959
- By:
- Publication type:
- Article
Evaluating the Clinical Impact of a Genomic Classifier in Prostate Cancer Using Individualized Decision Analysis.
- Published in:
- PLoS ONE, 2015, v. 10, n. 4, p. 1, doi. 10.1371/journal.pone.0116866
- By:
- Publication type:
- Article
Prognostic Value of Discs Large Homolog 7 Transcript Levels in Prostate Cancer.
- Published in:
- PLoS ONE, 2013, v. 8, n. 12, p. 1, doi. 10.1371/journal.pone.0082833
- By:
- Publication type:
- Article
Discovery and Validation of a Prostate Cancer Genomic Classifier that Predicts Early Metastasis Following Radical Prostatectomy.
- Published in:
- PLoS ONE, 2013, v. 8, n. 6, p. 1, doi. 10.1371/journal.pone.0066855
- By:
- Publication type:
- Article
Antiangiogenic Effects and Therapeutic Targets of Azadirachta indica Leaf Extract in Endothelial Cells.
- Published in:
- Evidence-based Complementary & Alternative Medicine (eCAM), 2012, v. 2012, p. 1, doi. 10.1155/2012/303019
- By:
- Publication type:
- Article
(S028) Patient-Level DNA Damage and Repair Pathway Profiles Are Prognostic After Prostatectomy for High-Risk Prostate Cancer.
- Published in:
- Oncology (08909091), 2015, v. 29, p. 1
- By:
- Publication type:
- Article
Node-Positive Prostate Cancer: A Call for Level 1 Evidence.
- Published in:
- 2015
- By:
- Publication type:
- Journal Article
Node-Positive Prostate Cancer: A Call for Level 1 Evidence.
- Published in:
- Oncology (08909091), 2015, v. 29, n. 2, p. 1
- By:
- Publication type:
- Article
The impact of treatment modality on survival in patients with clinical node-positive bladder cancer: results from a multicenter collaboration.
- Published in:
- World Journal of Urology, 2021, v. 39, n. 2, p. 443, doi. 10.1007/s00345-020-03205-z
- By:
- Publication type:
- Article
Reply letter to: Peyton CC, Tang D, Reich RR, et al. Downstaging and survival outcomes associated with neoadjuvant chemotherapy regimens among patients treated with cystectomy for muscle-invasive bladder cancer. JAMA Oncol. 2018 Nov 1;4(11):1535–1542
- Published in:
- 2020
- By:
- Publication type:
- Letter
Clinical predictors and survival outcome of patients receiving suboptimal neoadjuvant chemotherapy and radical cystectomy for muscle-invasive bladder cancer: a single-center experience.
- Published in:
- World Journal of Urology, 2019, v. 37, n. 11, p. 2409, doi. 10.1007/s00345-019-02689-8
- By:
- Publication type:
- Article
A risk-stratified approach to neoadjuvant chemotherapy in muscle-invasive bladder cancer: implications for patients classified with low-risk disease.
- Published in:
- World Journal of Urology, 2019, v. 37, n. 8, p. 1605, doi. 10.1007/s00345-018-2551-9
- By:
- Publication type:
- Article
Older patients with low Charlson score and high-risk prostate cancer benefit from radical prostatectomy.
- Published in:
- World Journal of Urology, 2016, v. 34, n. 10, p. 1367, doi. 10.1007/s00345-016-1784-8
- By:
- Publication type:
- Article
Performance of a Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography–Derived Risk-Stratification Tool for High-risk and Very High-risk Prostate Cancer.
- Published in:
- JAMA Network Open, 2021, v. 4, n. 12, p. e2138550, doi. 10.1001/jamanetworkopen.2021.38550
- By:
- Publication type:
- Article
18F-FDG PET/CT and Urothelial Carcinoma: Impact on Management and Prognosis—A Multicenter Retrospective Study.
- Published in:
- Cancers, 2019, v. 11, n. 5, p. 700, doi. 10.3390/cancers11050700
- By:
- Publication type:
- Article
AKT-phosphorylated FOXO1 suppresses ERK activation and chemoresistance by disrupting IQGAP1- MAPK interaction.
- Published in:
- EMBO Journal, 2017, v. 36, n. 8, p. 995, doi. 10.15252/embj.201695534
- By:
- Publication type:
- Article
Progress on Management of Penile Cancer in 2020.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Prognostic value of p53 and MIB‐1 in transitional cell carcinoma of the urinary bladder with regional lymph node involvement.
- Published in:
- Cancer (0008543X), 2004, v. 101, n. 8, p. 1803
- By:
- Publication type:
- Article
Transitional cell carcinoma of the urinary bladder with regional lymph node involvement treated by cystectomy.
- Published in:
- Cancer (0008543X), 2003, v. 97, n. 10, p. 2425, doi. 10.1002/cncr.11370
- By:
- Publication type:
- Article
Risk‑prediction tools in prostate cancer: the challenge of tailoring.
- Published in:
- Asian Journal of Andrology, 2016, v. 18, n. 6, p. 952, doi. 10.4103/1008-682X.179526
- By:
- Publication type:
- Article
Tumor subtype defines distinct pathways of molecular and clinical progression in primary prostate cancer.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Combining PSA and PET features to select candidates for salvage lymph node dissection in recurrent prostate cancer.
- Published in:
- BJUI Compass, 2023, v. 4, n. 1, p. 123, doi. 10.1002/bco2.182
- By:
- Publication type:
- Article
Age and Prostate-Specific antigen level Prior to Diagnosis Predict risk of Death from Prostate cancer.
- Published in:
- Frontiers in Oncology, 2016, p. 1, doi. 10.3389/fonc.2016.00157
- By:
- Publication type:
- Article
Radical Prostatectomy for High-risk Prostate Cancer*.
- Published in:
- Japanese Journal of Clinical Oncology, 2010, v. 40, n. 1, p. 3, doi. 10.1093/jjco/hyp130
- By:
- Publication type:
- Article
Phenethyl isothiocyanate inhibits STAT3 activation in prostate cancer cells.
- Published in:
- Molecular Nutrition & Food Research, 2009, v. 53, n. 7, p. 878, doi. 10.1002/mnfr.200800253
- By:
- Publication type:
- Article
Adding carboplatin to chemotherapy regimens for metastatic castrate‐resistant prostate cancer in postsecond generation hormone therapy setting: Impact on treatment response and survival outcomes.
- Published in:
- Prostate, 2020, v. 80, n. 14, p. 1216, doi. 10.1002/pros.24048
- By:
- Publication type:
- Article
Systemic treatment for metastatic castrate resistant prostate cancer: Does seqence matter?
- Published in:
- Prostate, 2020, v. 80, n. 5, p. 399, doi. 10.1002/pros.23954
- By:
- Publication type:
- Article
A four‐gene transcript score to predict metastatic‐lethal progression in men treated for localized prostate cancer: Development and validation studies.
- Published in:
- Prostate, 2019, v. 79, n. 14, p. 1589, doi. 10.1002/pros.23882
- By:
- Publication type:
- Article
Epigenetic regulation of Myc on retinoic acid receptor beta and PDLIM4 in RWPE1 cells.
- Published in:
- Prostate, 2009, v. 69, n. 15, p. 1643, doi. 10.1002/pros.21013
- By:
- Publication type:
- Article
Long-Term Outcomes of Prostate-Specific Membrane Antigen–PET Imaging of Recurrent Prostate Cancer.
- Published in:
- JAMA Network Open, 2024, v. 7, n. 10, p. e2440591, doi. 10.1001/jamanetworkopen.2024.40591
- By:
- Publication type:
- Article
Comparison between the diagnostic accuracies of 18F-fluorodeoxyglucose positron emission tomography/computed tomography and conventional imaging in recurrent urothelial carcinomas: a retrospective, multicenter study.
- Published in:
- Abdominal Radiology, 2018, v. 43, n. 9, p. 2391, doi. 10.1007/s00261-017-1443-6
- By:
- Publication type:
- Article
Standard and saturation transrectal prostate biopsy techniques are equally accurate among prostate cancer active surveillance candidates.
- Published in:
- International Journal of Urology, 2013, v. 20, n. 9, p. 860, doi. 10.1111/iju.12061
- By:
- Publication type:
- Article
Interaction of adjuvant androgen deprivation therapy with patient comorbidity status on overall survival after radical prostatectomy for high-risk prostate cancer.
- Published in:
- International Journal of Urology, 2013, v. 20, n. 8, p. 798, doi. 10.1111/iju.12047
- By:
- Publication type:
- Article